symbol,statement_type,period_end,line_item,value
BIOCON.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,17179000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-97699000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,96582000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,104000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-23433000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,End Cash Position,29238000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,9195000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,312000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,19731000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-18540000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,-15814000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-6342000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-829000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,104000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,104000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,5729000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,6846000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-1117000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-97699000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,96582000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-2341000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,1144000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,28000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,1665000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,104082000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-102417000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,18252000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Sale Of Business,18252000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,0.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,-2067000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,-2067000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-21363000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,3000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-21366000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,40612000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-4596000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,9230000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-2057000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Change In Payable,5808000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-3000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,5482000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-1305000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,1370000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,260000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Deferred Tax,4572000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,16870000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
BIOCON.NS,cashflow,2025-03-31 00:00:00,Depreciation,16870000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,387000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-576000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,76000000.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
BIOCON.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,14294000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,10223000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,0.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-27678000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,13718000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,307000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-19316000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,End Cash Position,9195000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
BIOCON.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,12999000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,29000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-3833000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-23327000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
BIOCON.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-8474000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-2030000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,307000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,0.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,307000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-12712000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,1248000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-13960000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-27678000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,13718000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-10045000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
BIOCON.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,1446000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,0.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,13124000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,66464000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-53340000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,-5532000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Sale Of Business,0.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,-5532000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,-2511000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,-2511000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-16572000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,233000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-16805000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,29539000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-2923000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-6352000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-2679000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Change In Payable,29365000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-8864000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-24174000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,14247000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,1006000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,-182000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Deferred Tax,2274000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,15688000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,6295000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Depreciation,15688000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-1701000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-1054000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,12000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of Business,-5307000000.0
BIOCON.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,12978000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,1262000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,-647000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-281000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,109399000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,12663000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-17263000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,End Cash Position,12948000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
BIOCON.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,6537000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,217000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,6194000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,130487000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
BIOCON.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-4856000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-718000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-718000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,12016000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,-647000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,12663000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,124159000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,15041000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,109118000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-281000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,109399000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-142818000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
BIOCON.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,1233000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-4648000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,182495000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-187143000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,-122171000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Sale Of Business,34474000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,-156645000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-1303000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-1303000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-15929000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,31000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-15960000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,18525000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-2286000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-5010000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,7582000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-37359000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,8862000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,15905000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,3564000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,1376000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,54000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Deferred Tax,2541000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,11131000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,2914000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Depreciation,8217000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-416000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,971000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,52000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of Business,-1562000000.0
BIOCON.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,6430000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-7482000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,-3000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-10949000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,10701000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,428000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-19248000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,End Cash Position,6537000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,338000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,8970000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,33000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-2804000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,2421000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
BIOCON.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-1096000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,
BIOCON.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,0.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,425000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,-3000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,428000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,3213000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,3461000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-248000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-10949000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,10701000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-16991000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
BIOCON.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,596000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,2314000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,80250000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-77936000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,0.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Sale Of Business,0.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,0.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-2270000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-2270000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-16957000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,21000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-16978000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,11766000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-2620000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-7895000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-637000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Change In Payable,1618000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-4140000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-4736000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,771000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,1257000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,240000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Deferred Tax,2115000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,8142000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,1310000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Depreciation,6832000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,153000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,86000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,23000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of Business,-299000000.0
BIOCON.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,7716000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,-93000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
BIOCON.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-338000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,-93000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,-1018000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Sale Of Business,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Deferred Tax,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,1131000000.0
BIOCON.NS,cashflow,2021-03-31 00:00:00,Depreciation,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of Business,
BIOCON.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
